Alessia Ferrarini
Overview
Explore the profile of Alessia Ferrarini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rojas-Gomez A, Dosil S, Chichon F, Fernandez-Gallego N, Ferrarini A, Calvo E, et al.
J Extracell Vesicles
. 2023 Jun;
12(6):e12333.
PMID: 37328936
Cell proteostasis includes gene transcription, protein translation, folding of de novo proteins, post-translational modifications, secretion, degradation and recycling. By profiling the proteome of extracellular vesicles (EVs) from T cells, we...
2.
Ferrarini A, Vacca A, Solimando A, Tavio M, Acquaviva R, Rocchi M, et al.
Eur J Clin Invest
. 2022 Nov;
53(2):e13898.
PMID: 36380693
Background: Controversies on sub-populations most sensitive to therapy and the best timing of starting the treatment still surround the use of immunomodulatory drugs in COVID-19. Objectives: We designed a multicentre...
3.
Barrero-Rodriguez R, Rodriguez J, Tarifa R, Vazquez J, Mastrangelo A, Ferrarini A
Front Mol Biosci
. 2022 Sep;
9:952149.
PMID: 36158581
Untargeted metabolomics aims at measuring the entire set of metabolites in a wide range of biological samples. However, due to the high chemical diversity of metabolites that range from small...
4.
Giuliani A, Matacchione G, Ramini D, Di Rosa M, Bonfigli A, Sabbatinelli J, et al.
Mech Ageing Dev
. 2022 Feb;
202:111636.
PMID: 35122770
The stratification of mortality risk in COVID-19 patients remains extremely challenging for physicians, especially in older patients. Innovative minimally invasive molecular biomarkers are needed to improve the prediction of mortality...
5.
Menendez-Montes I, Escobar B, Gomez M, Albendea-Gomez T, Palacios B, Bonzon-Kulichenko E, et al.
iScience
. 2021 Mar;
24(2):102124.
PMID: 33665549
HIF1-alpha expression defines metabolic compartments in the developing heart, promoting glycolytic program in the compact myocardium and mitochondrial enrichment in the trabeculae. Nonetheless, its role in cardiogenesis is debated. To...
6.
Sabbatinelli J, Giuliani A, Matacchione G, Latini S, Laprovitera N, Pomponio G, et al.
Mech Ageing Dev
. 2020 Dec;
193:111413.
PMID: 33307107
Current COVID-19 pandemic poses an unprecedented threat to global health and healthcare systems. The most amount of the death toll is accounted by old people affected by age-related diseases that...
7.
Lorenzo C, Delgado P, Busse C, Sanz-Bravo A, Martos-Folgado I, Bonzon-Kulichenko E, et al.
Nature
. 2020 Dec;
589(7841):287-292.
PMID: 33268892
Cardiovascular disease (CVD) is the leading cause of mortality in the world, with most CVD-related deaths resulting from myocardial infarction or stroke. The main underlying cause of thrombosis and cardiovascular...
8.
ECM deposition is driven by caveolin-1-dependent regulation of exosomal biogenesis and cargo sorting
Albacete-Albacete L, Navarro-Lerida I, Lopez J, Martin-Padura I, Astudillo A, Ferrarini A, et al.
J Cell Biol
. 2020 Oct;
219(11).
PMID: 33053168
The composition and physical properties of the extracellular matrix (ECM) critically influence tumor progression, but the molecular mechanisms underlying ECM layering are poorly understood. Tumor-stroma interaction critically depends on cell...
9.
Stronati G, Manfredi L, Ferrarini A, Zuliani L, Fogante M, Schicchi N, et al.
Eur J Prev Cardiol
. 2020 Apr;
27(17):1876-1886.
PMID: 32306757
Aims: Cardiac involvement in patients with systemic sclerosis (SSc) is frequent and represents a negative prognostic factor. Recent studies have described subclinical heart involvement of both the right ventricle (RV)...
10.
Barefoot M, Varghese R, Zhou Y, Di Poto C, Ferrarini A, Ressom H
Annu Int Conf IEEE Eng Med Biol Soc
. 2020 Jan;
2019:1350-1354.
PMID: 31946143
The threat of Hepatocellular Carcinoma (HCC) is a growing problem, with incidence rates anticipated to near double over the next two decades. The increasing burden makes discovery of novel diagnostic,...